Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL4185 Target Snapshot

Xaa-Pro dipeptidase · SINGLE PROTEIN · Homo sapiens

126Compounds
30Assays
3Approved Drugs
135.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt P12955. Use UniProt P12955 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P12955 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Xaa-Pro dipeptidase as ChEMBL target CHEMBL4185, mapped to UniProt P12955. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Xaa-Pro dipeptidase
SINGLE PROTEIN · Homo sapiens
As of 2026-09-13
ChEMBL target ID
CHEMBL4185
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
P12955
Xaa-Pro dipeptidase
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Xaa-Pro dipeptidase is the right protein anchor across sources, using UniProt P12955 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelXaa-Pro dipeptidase
UniProt AccessionP12955
Component TypeProtein
Sequence Length493 aa

Xaa-Pro dipeptidase

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Xaa-Pro dipeptidase, mapped to UniProt P12955. Sequence length is 493 aa.

Mapped IDP12955
Review nameXaa-Pro dipeptidase
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

3
Approved
Assay Mix

Activity Type Distribution

IC50126.0
KI8.0
KD1.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL1235228 8.07 Ki 8.5 Preclinical
CHEMBL96505 6.57 Ki 270.0 Preclinical
CHEMBL5419166 6.55 IC50 280.0 Preclinical
CHEMBL5433567 6.54 IC50 290.0 Preclinical
CHEMBL178 6.52 IC50 300.0 Approved
CHEMBL5435351 6.52 IC50 300.0 Preclinical
CHEMBL5429139 6.28 IC50 530.0 Preclinical
CHEMBL5653589 6.26 Kd 547.31 Preclinical
CHEMBL5433668 6.25 IC50 560.0 Preclinical
CHEMBL2369858 6.18 IC50 660.0 Preclinical
Distribution

pChEMBL Value Distribution

12
5.0
13
5.5
11
6.0
6
6.5
0
7.0
0
7.5
1
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

DAUNORUBICIN
CHEMBL178
Approved 1979
Assay Landscape

Assay Landscape

31
Total Assays
58
Tested Compounds
1
Assay Types
Binding — 31 assays, 58 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 26 57 5.6
cell-based format 5 1 5.0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine